Current stock page

Catalysts

AXGN Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareMedical - DevicesScore data as of Nov 18, 2026

AXGNAxoGen, Inc.

Healthcare / Medical - Devices

Absolute Strength

Above Peers

BullishEdge 7/10
$56.95+$1.58 (+2.85%)

Latest quote

  • Momentum
    82
  • Value
    33
  • Quality
    70
  • Risk resilience
    55
  • Sentiment
    —
algovestiq.comScore data as of Nov 18, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Feb 23, 2027

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 65/100

Momentum 82/100 and sentiment — before the next covered event.

Recent coverage
4 articles

Updated Nov 18, 2026 · Sentiment 6.85%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 82/100AIQ Edge 7/10 Above Peers
Beat rate
50%
4 of 8 reported periods
Average surprise
+16.2%
Across covered historical reports
Latest result
+59.9%
Oct 28, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Oct 28, 2026—$0.13$0.21+59.9%$73.45M$75.83M
Jul 29, 2026—$0.12$0.12-1.2%$67.1M$69.73M
Apr 28, 2026—$0.12$0.07-41.7%$57.85M$61.46M
Feb 24, 2026—$0.09$0.07-21.2%$59.03M$59.9M
Oct 29, 2025—$0.09$0.12+33.3%$59.9M$60.08M
Aug 5, 2025—$0.06$0.12+100.0%$56.89M$56.66M
May 8, 2025—-$0.01-$0.02-100.0%$53.34M$48.56M
Feb 25, 2025—$0.04$0.08+100.0%$48.28M$49.41M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
11
Buy
12-month analyst target
$58.13
+2.06% versus current price
Based on 11 analyst observations. Targets are estimates, not predictions.
Low target
$53.00
-6.94% vs latest price
Average target
$58.13
+2.06% vs latest price
High target
$65.00
+14.14% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateFeb 23, 2027

Next known earnings or reporting date.

EPS estimate$0.15

Current analyst expectation for the upcoming report.

Revenue estimate$83.3M

Current analyst expectation for the upcoming report.

Sentiment score—

News pressure around the setup.

Momentum score82

Where event reaction would show up first.

AIQ score65/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
11
Average target
$58.13
Target upside
2.06%
Target range
$53.00 - $65.00

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
1
Neutral
2
Negative
1
seekingalpha.com · Nov 9, 2026

Axogen, Inc. (AXGN) Discusses Prostate Nerve Reconstruction Market Development Transcript

Axogen, Inc. (AXGN) Discusses Prostate Nerve Reconstruction Market Development November 9, 2026 9:00 AM ESTCompany ParticipantsMichael Dale - President, CEO...

seekingalpha.com · Oct 30, 2026

Axogen: Taking The Friction Out Of Nerve Repair (NASDAQ:AXGN)

Axogen (AXGN) is evolving from a growth story to the default procedural platform in peripheral nerve repair, protected by a regulatory moat for the next...

gurufocus.com · Oct 28, 2026

Q3 2026 AxoGen, Inc. Earnings Call Transcript

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NAXGN.OQ - AxoGen, Inc.Q3 2026 AxoGen, Inc. Earnings CallOct 28, 2026 / 12:00PM GMT ===========

seekingalpha.com · Oct 28, 2026

Axogen forecasts at least $290M 2026 revenue, adds $7M from BioCircuit while planning prostate market development in 2027 (NASDAQ:AXGN)

Axogen Q3 2026 earnings: revenue jumped 26%, guidance rose to $290M, and BioCircuit adds NerveTape growth potential.

Open full news and sentiment

AXGN Catalysts FAQ

What are the next catalysts for AXGN stock?

AXGN's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move AXGN stock?

Upcoming events that could move AXGN include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could AXGN's next earnings report affect the stock?

AXGN's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive AXGN stock higher?

AXGN could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt AXGN stock?

AXGN could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.